Salem Investment Counselors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$124K Sell
1,576
-74
-4% -$5.97K ﹤0.01% 468
2026
Q1
$144K Buy
+1,650
New +$158K ﹤0.01% 423
2025
Q4
Sell
-1,587
Closed -$152K 843
2025
Q3
$152K Buy
1,587
+174
+12% +$16K ﹤0.01% 398
2025
Q2
$124K Sell
1,413
-112
-7% -$9.5K ﹤0.01% 421
2025
Q1
$138K Buy
1,525
+422
+38% +$37.8K ﹤0.01% 398
2024
Q4
$89K Sell
1,103
-227
-17% -$19.7K ﹤0.01% 477
2024
Q3
$121K Sell
1,330
-194
-13% -$16.3K ﹤0.01% 429
2024
Q2
$121K Sell
1,524
-447
-23% -$36.6K ﹤0.01% 420
2024
Q1
$173K Sell
1,971
-43
-2% -$3.67K 0.01% 379
2023
Q4
$167K Buy
2,014
+366
+22% +$27.9K 0.01% 371
2023
Q3
$130K Sell
1,648
-30
-2% -$2.51K 0.01% 386
2023
Q2
$149K Sell
1,678
-460
-22% -$39.6K 0.01% 365
2023
Q1
$174K Buy
2,138
+635
+42% +$51.8K 0.01% 357
2022
Q4
$118K Sell
1,503
-365
-20% -$29.6K 0.01% 390
2022
Q3
$152K Buy
1,868
+507
+37% +$45.6K 0.01% 340
2022
Q2
$123K Sell
1,361
-495
-27% -$50.2K 0.01% 386
2022
Q1
$206K Sell
1,856
-244
-12% -$25.8K 0.01% 340
2021
Q4
$217K Buy
2,100
+107
+5% +$12.4K 0.01% 361
2021
Q3
$250K Hold
1,993
0.01% 316
2021
Q2
$247K Hold
1,993
0.01% 301
2021
Q1
$235K Buy
1,993
+120
+6% +$14.1K 0.01% 271
2020
Q4
$219K Buy
1,873
+299
+19% +$32.9K 0.01% 271
2020
Q3
$164K Hold
1,574
0.01% 259
2020
Q2
$144K Hold
1,574
0.01% 264
2020
Q1
$142K Sell
1,574
-235
-13% -$25K 0.01% 255
2019
Q4
$205K Buy
1,809
+980
+118% +$108K 0.02% 241
2019
Q3
$90K Hold
829
0.01% 316
2019
Q2
$81K Hold
829
0.01% 324
2019
Q1
$82K Buy
+829
New +$74.2K 0.01% 254
2018
Q4
Sell
-829
Closed -$82K 295
2018
Q3
$82K Sell
829
-800
-49% -$74K 0.01% 254
2018
Q2
$139K Buy
1,629
+400
+33% +$33.4K 0.01% 216
2018
Q1
$96K Sell
1,229
-250
-17% -$20.6K 0.01% 231
2017
Q4
$119K Sell
1,479
-635
-30% -$50.9K 0.01% 232
2017
Q3
$165K Hold
2,114
0.02% 202
2017
Q2
$188K Buy
2,114
+123
+6% +$10.4K 0.02% 204
2017
Q1
$160K Sell
1,991
-777
-28% -$60.7K 0.02% 250
2016
Q4
$197K Buy
+2,768
New +$217K 0.02% 236
2016
Q3
Sell
-5,248
Closed -$455K 536
2016
Q2
$455K Sell
5,248
-100
-2% -$8.09K 0.05% 185
2016
Q1
$401K Buy
5,348
+500
+10% +$37.7K 0.05% 189
2015
Q4
$373K Hold
4,848
0.05% 198
2015
Q3
$322K Sell
4,848
-600
-11% -$44.2K 0.04% 207
2015
Q2
$404K Hold
5,448
0.05% 203
2015
Q1
$425K Sell
5,448
-643
-11% -$48.7K 0.05% 205
2014
Q4
$440K Sell
6,091
-300
-5% -$20.8K 0.05% 197
2014
Q3
$396K Hold
6,391
0.05% 209
2014
Q2
$407K Sell
6,391
-31,450
-83% -$1.91M 0.05% 209
2014
Q1
$2.33M Sell
37,841
-400
-1% -$23.3K 0.29% 89
2013
Q4
$2.19M Sell
38,241
-132
-0.3% -$7.49K 0.29% 89
2013
Q3
$2.04M Hold
38,373
0.28% 87
2013
Q2
$1.98M Buy
+38,373
New +$1.9M 0.29% 83

Other funds holding MDT

Salem Investment Counselors's MDT Position: Q2 2026 in Review

Salem Investment Counselors reduced its Medtronic (MDT) stake by 4.5% in Q2 2026, selling an estimated $5.97K and leaving 1,576 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #468.

Salem Investment Counselors first reported a position in MDT in Q2 2013 and has held it in 50 quarters since. The position peaked at $2.33M in Q1 2014. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Salem Investment Counselors held 1,576 shares of Medtronic worth $124K as of Q2 2026.
  • Salem Investment Counselors sold 74 Medtronic shares in Q2 2026, an estimated $5.97K.
  • Medtronic made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #468 holding.
  • Salem Investment Counselors first reported a position in Medtronic in Q2 2013 and has held it in 50 quarters since.
  • Salem Investment Counselors's Medtronic position peaked at $2.33M in Q1 2014.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.